EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Clinical, Immunological, and Metabolic Features Associated with Persistent Post-Acute COVID-19 Syndrome

Karina Santana-de Anda, Jiram Torres-Ruiz, Nancy R Mejía-Domínguez iD, Beatriz Alcalá-Carmona, José L Maravillas-Montero iD, José Carlos Páez-Franco iD, Ana Sofía Vargas-Castro, Jaquelin Lira-Luna iD, Emmanuel A Camacho-Morán, Guillermo Juarez-Vega iD, David Meza-Sánchez, Carlos Núñez-Álvarez und 2 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25179661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Karina Santana-de Anda und 13 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico. Hauptthemen laut MEDLINE: COVID-19, Post-Acute COVID-19 Syndrome, SARS-CoV-2. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo de Apoyo a Proyectos de Investigación en el Campo de la Salud.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The coronavirus disease 2019 (COVID-19) survivors are frequently observed to present persistent symptoms constituting what has been called “post-acute COVID-19 syndrome” (PACS) or “long COVID-19”. Some clinical risk factors have been identified to be associated with PACS development; however, specific mechanisms responsible for PACS pathology remain unknown. This study investigates clinical, immunological, and metabolomic risk factors associated with post-acute COVID-19 syndrome (PACS) in 51 patients, assessed 7–19 months after acute infection. Among the participants, 62.7% were male and 37.2% were female, with an average age of 47.8 years. At the follow-up, 37.2% met the criteria for PACS, revealing significant differences in immunological and metabolomic profiles at the time of acute infection. Patients with PACS were characterized by elevated levels of mature low-density granulocytes (LDGs), interleukin-8 (IL-8), pyruvate, pseudouridine, and cystine. Baseline multivariate analysis showed increased pyruvate and decreased alpha tocopherol levels. At follow-up, there was a decrease in absolute B lymphocytes and an increase in non-classical monocytes and 3-hydroxyisovaleric acid levels. These findings suggest that specific immunological and metabolomic markers during acute infection can help identify patients at higher risk of developing persistent PACS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Post-Acute COVID-19 SyndromeSARS-CoV-2HumansFemaleMaleMiddle AgedAdultRisk FactorsBiomarkersMetabolomicsAgedMetabolomeInterleukin-8

Stichwörter der Autor:innen

B cellschemokinesmetabolomicsmonocytesneutrophilspersistent PACS

Substanzen

BiomarkersInterleukin-8

Autor:innen und Institutionen

  • Immunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.
  • Red de Apoyo a la Investigación, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico.
  • Hospital Angeles Pedregal, Mexico City 10700, Mexico.
  • Departamento de Cirugía General, Hospital Regional 1ro de Octubre, ISSSTE, Mexico City 07760, Mexico.
  • Departamento de Medicina Crítica, Instituto Nacional de Perinatología, Isidro Espinosa de los Reyes, Mexico City 11000, Mexico.

ORCID-Profile: Nancy R Mejía-Domínguez, José L Maravillas-Montero, José Carlos Páez-Franco, Jaquelin Lira-Luna, Guillermo Juarez-Vega, Diana Gómez-Martín

Förderung

  • Fondo de Apoyo a Proyectos de Investigación en el Campo de la Salud

Zitieren

APA

Santana-de Anda, K., Torres-Ruiz, J., Mejía-Domínguez, N. R., Alcalá-Carmona, B., Maravillas-Montero, J. L., Páez-Franco, J. C., Vargas-Castro, A. S., Lira-Luna, J., Camacho-Morán, E. A., Juarez-Vega, G., Meza-Sánchez, D., Núñez-Álvarez, C., Rull-Gabayet, M., & Gómez-Martín, D. (2024). Novel Clinical, Immunological, and Metabolic Features Associated with Persistent Post-Acute COVID-19 Syndrome. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179661

Vancouver

Santana-de Anda K, Torres-Ruiz J, Mejía-Domínguez NR, Alcalá-Carmona B, Maravillas-Montero JL, Páez-Franco JC, et al. Novel Clinical, Immunological, and Metabolic Features Associated with Persistent Post-Acute COVID-19 Syndrome. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179661

BibTeX
@article{SantanadeAnda2024,
  author = {Santana-de Anda, Karina and Torres-Ruiz, Jiram and Mejía-Domínguez, Nancy R and Alcalá-Carmona, Beatriz and Maravillas-Montero, José L and Páez-Franco, José Carlos and Vargas-Castro, Ana Sofía and Lira-Luna, Jaquelin and Camacho-Morán, Emmanuel A and Juarez-Vega, Guillermo and Meza-Sánchez, David and Núñez-Álvarez, Carlos and Rull-Gabayet, Marina and Gómez-Martín, Diana},
  title = {Novel Clinical, Immunological, and Metabolic Features Associated with Persistent Post-Acute COVID-19 Syndrome},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25179661}
}
Kostenlos starten →